ABL tyrosine kinase inhibitor-induced pulmonary alveolar proteinosis in chronic myeloid leukemia.
about
GM-CSF Autoantibody-positive Pulmonary Alveolar Proteinosis with Simultaneous Myeloproliferative NeoplasmPulmonary alveolar proteinosis: time to shift?Two cases of autoimmune and secondary pulmonary alveolar proteinosis during immunosuppressive therapy in dermatomyositis with interstitial lung disease.
P2860
ABL tyrosine kinase inhibitor-induced pulmonary alveolar proteinosis in chronic myeloid leukemia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
ABL tyrosine kinase inhibitor- ...... s in chronic myeloid leukemia.
@en
ABL tyrosine kinase inhibitor- ...... s in chronic myeloid leukemia.
@nl
type
label
ABL tyrosine kinase inhibitor- ...... s in chronic myeloid leukemia.
@en
ABL tyrosine kinase inhibitor- ...... s in chronic myeloid leukemia.
@nl
prefLabel
ABL tyrosine kinase inhibitor- ...... s in chronic myeloid leukemia.
@en
ABL tyrosine kinase inhibitor- ...... s in chronic myeloid leukemia.
@nl
P2093
P2860
P1476
ABL tyrosine kinase inhibitor- ...... s in chronic myeloid leukemia.
@en
P2093
Eisaburo Sueoka
Kensuke Kojima
Mariko Yoshimura
Noriyasu Fukushima
Rika Tomimasu
Shinichiro Hayashi
Shinya Kimura
P2860
P2888
P304
P356
10.1007/S12185-014-1666-Z
P577
2014-09-12T00:00:00Z